Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term follow-up of children conditioned with Treosulfan: German and Austrian experience.
Beier R, Schulz A, Hönig M, Eyrich M, Schlegel PG, Holter W, Stachel KD, Ehlert K, Greil J, Nürnberger W, Wössmann W, Bader P, Urban C, Müller I, Suttorp M, Sauer M, Gruhn B, Meisel R, Zimmermann M, Sykora KW. Beier R, et al. Among authors: schlegel pg. Bone Marrow Transplant. 2013 Apr;48(4):491-501. doi: 10.1038/bmt.2012.188. Epub 2012 Oct 22. Bone Marrow Transplant. 2013. PMID: 23085832 Clinical Trial.
Impact of regional SARS-CoV-2 proceedings on changes in diagnoses of pediatric malignancies in Bavaria during the COVID-19 pandemic.
Reger M, Manz K, Kaeuferle T, Coffey R, Wotschofsky Z, von Luettichau I, Schlegel PG, Frühwald MC, Corbacioglu S, Metzler M, Feuchtinger T. Reger M, et al. Among authors: schlegel pg. Pediatr Hematol Oncol. 2024 Oct;41(7):504-518. doi: 10.1080/08880018.2024.2393623. Epub 2024 Sep 5. Pediatr Hematol Oncol. 2024. PMID: 39235390
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, Bochennek K, Gruhn B, Lang P, Rohde M, Debatin KM, Steinbach D, Beilken A, Ladenstein R, Spachtholz R, Heiss P, Hellwig D, Tröger A, Koller M, Menhart K, Riemenschneider MJ, Zoubaa S, Kietz S, Jakob M, Sommer G, Heise T, Hundsdörfer P, Kühnle I, Dilloo D, Schönberger S, Schwabe G, von Luettichau I, Graf N, Schlegel PG, Frühwald M, Jorch N, Paulussen M, Schneider DT, Metzler M, Leipold A, Nathrath M, Imschweiler T, Christiansen H, Schmid I, Crazzolara R, Niktoreh N, Cario G, Faber J, Demmert M, Babor F, Fröhlich B, Bielack S, Bernig T, Greil J, Eggert A, Simon T, Foell J. Corbacioglu S, et al. Among authors: schlegel pg. Lancet Oncol. 2024 Jul;25(7):922-932. doi: 10.1016/S1470-2045(24)00202-X. Lancet Oncol. 2024. PMID: 38936379 Free article. Clinical Trial.
Assessment of prognostic factors in pediatric adrenocortical tumors: the modified pediatric S-GRAS score in an international multicenter cohort-a work from the ENSAT-PACT working group.
Riedmeier M, Agarwal S, Antonini S, Costa TEIJB, Diclehan O, Fassnacht M, Figueiredo BC, Guran T, Härtel C, Haubitz I, Idkowiak J, Kuhlen M, Noronha L, Parise IZS, Redlich A, Puglisi S, Saniye E, Schlegel PG, Yalcin B, Wiegering V. Riedmeier M, et al. Among authors: schlegel pg. Eur J Endocrinol. 2024 Jul 2;191(1):64-74. doi: 10.1093/ejendo/lvae079. Eur J Endocrinol. 2024. PMID: 38924056
186 results